News

Balkan Pharmaceuticals awarded the Notorium Trophy for the 7th time in a row

Balkan Pharmaceuticals awarded the Notorium Trophy for the 7th time in a row
Balkan Pharmaceuticals was awarded the Notorium trophy for the 7th consecutive year. This year, Balkan Pharmaceuticals won 2 Notorium 1st place trophies, in the Pharmaceutical Products category and the Optics category.

These awards prove the consistency of the policies adopted by the company over the years, but also the public appreciation for the Balkan Pharmaceuticals branded products.

Cazacu Radu, pharmacist, Balkan Pharmaceuticals representative:
"The seven years of the Notorium Awards Gala provided us with more than 10 awards. This is not just a praise but 10 reasons to become better, 10 reasons to thank all the pharmacists, doctors, patients who supported us and were always by our side, and 10 arguments to prove that we can achieve notorious things, here, at home.

A strong point of the coming year is the completion of a project we have been working on for over 3 years. It involves a technology exchange between the International Center for Genetics and Bioenergy and Balkan Pharmaceuticals, under the auspices of the World Health Organization. The project involves the creation of quality biological materials such as insulin and other hormones, here at home, which will allow strengthening the importance of the domestic manufacturers, because until now this kind of preparations were only imported".




Balkan Pharmaceuticals is the largest Romanian private capital investment in the Republic of Moldova and the only producer of injectable and infusible forms in the country.











The Notorium trophy is a highly prestigious award that recognizes businesses for their growth and significance in their respective industries. Balkan Pharmaceuticals is proud to be a 7-time winner of this prestigious award, and we are especially proud to have won 2 1st place trophies this year. This is a testament to our commitment to excellence and our dedication to providing the best possible products and services to patients. We would like to thank our partners for their continued support, and we look forward to continued growth and success in the future.

Source: Agora.md